Regression of CTCL lesions after tumor-lysate-pulsed DC vaccination. Regression of infiltrated plaques of patient 8 (A, before therapy), leaving an area of residual erythema without palpable infiltration (B, after therapy). Regression of tumors, plaques, and patches in patient 1 (C, before therapy; D, after therapy).